Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,760,940
-
Share change
-
+58,886
-
Total reported value
-
$26,089,539
-
Price per share
-
$9.45
-
Number of holders
-
29
-
Value change
-
+$264,194
-
Number of buys
-
14
-
Number of sells
-
12
Institutional Holders of ZYNERBA PHARMACEUTICALS INC - COM (ZYNE) as of Q1 2016
As of 31 Mar 2016,
ZYNERBA PHARMACEUTICALS INC - COM (ZYNE) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,760,940 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, RA CAPITAL MANAGEMENT, LLC, Cormorant Asset Management, LLC, VANGUARD GROUP INC, JPMORGAN CHASE & CO, EMERALD ADVISERS INC/PA, BlackRock Fund Advisors, AUXIER ASSET MANAGEMENT, Nationwide Fund Advisors, and STATE STREET CORP.
This page lists
29
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.